Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Filingeri

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Drugs Under Experimental and Clinical Research|January 1, 1991
Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in ratsA Iacona, A Rossetti, V Filingeri, et al.
Minerva Chirurgica|November 7, 2003
[Description of a case of giant adrenal myelolipoma and survey of the literature]B Iorio, G Gravante, D Pietrasanta, et al.
Minerva Medica|May 1, 1990
[Cyclosporin (CyA) and H2 antagonists]V Filingeri, R Rosati, A Iacona, et al.
Minerva Chirurgica|March 1, 1995
[Synergism between cyclosporin and gangliosides in anti-rejection therapy. Experimental in vivo model]V Filingeri, R Rosati, G Sconocchia, et al.
Drugs Under Experimental and Clinical Research|January 1, 1990
Drug interaction between cyclosporin A and nizatidine in Sprague-Dawley ratsV Filingeri, R Rosati, R Giacomelli, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Evidence of drug interaction between cyclosporin A and H2-receptor antagonists (cimetidine, ranitidine and famotidine) in Sprague-Dawley ratsV Filingeri, R Giacomelli, G Famularo, et al.
Transplantation Proceedings|October 1, 1990
Cyclosporine and the ischemic rat liverF Stortoni, C M Durante, V Cervelli, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Drugs Under Experimental and Clinical Research|January 1, 1991
Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in ratsA Iacona, A Rossetti, V Filingeri, et al.
Minerva Chirurgica|November 7, 2003
[Description of a case of giant adrenal myelolipoma and survey of the literature]B Iorio, G Gravante, D Pietrasanta, et al.
Minerva Medica|May 1, 1990
[Cyclosporin (CyA) and H2 antagonists]V Filingeri, R Rosati, A Iacona, et al.
Minerva Chirurgica|March 1, 1995
[Synergism between cyclosporin and gangliosides in anti-rejection therapy. Experimental in vivo model]V Filingeri, R Rosati, G Sconocchia, et al.
Drugs Under Experimental and Clinical Research|January 1, 1990
Drug interaction between cyclosporin A and nizatidine in Sprague-Dawley ratsV Filingeri, R Rosati, R Giacomelli, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Evidence of drug interaction between cyclosporin A and H2-receptor antagonists (cimetidine, ranitidine and famotidine) in Sprague-Dawley ratsV Filingeri, R Giacomelli, G Famularo, et al.
Transplantation Proceedings|October 1, 1990
Cyclosporine and the ischemic rat liverF Stortoni, C M Durante, V Cervelli, et al.
Pageof 5